18.06.2010 • NewsDowStyronportfolio

Dow Closes Sale of Styron Division

Dow has completed of the sale of styron division to Bain Capital for $1.63 billion. The company said it elected to retain a 7.5% equity position in Styron. Dow also said the closure has helped the company exceed its goal of divesting $5 billion in non-strategic assets,

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read